Las Vegas—A collaboration between gastroenterologists and pharmacists to establish a standardized protocol for use of biologics in inflammatory bowel disease has changed routine practice in a multicenter system and improved several quality-of-care benchmarks.
“A pharmacist-gastroenterologist co-management program for use of biologics in IBD patients is superior to a traditional gastroenterologist-only model with regard to laboratory screening prior to treatment and monitoring after